The global gene detection market is poised for substantial growth in the coming years, driven by a surge in cancer testing. Gene detection methods have become instrumental in diagnosing mutations and DNA variants associated with the excessive growth of cells, increasing the risk of tumor development. Various gene detection techniques such as CHEK2, RAD51D, BRIP1, and PALB2 have been instrumental in detecting colorectal, breast, ovarian, and pancreatic cancers, respectively. The escalating global cancer burden has led to heightened awareness, driving demand for gene detection services.
According to the Global Cancer Observatory, there were 19,292,789 cancer cases worldwide in 2020, resulting in 9,958,133 deaths. The International Agency for Research on Cancer (IARC) predicts that new cancer incidences could reach 30 million by 2040. Gene detection offers the possibility of identifying cancer risk within families, aiding in early prevention and personalized medicine adoption. Additionally, for chemotherapy-resistant patients, gene detection can pinpoint mutations in therapy-resistant cancer cells, enabling tailored treatment approaches.
Technological advancements have further accelerated the adoption of gene detection in cancer testing. In December 2020, Roche introduced Cobas PIK3CA, a mutation test for metastatic or advanced breast cancer, illustrating the evolving landscape of gene detection in healthcare.
Prevalence of Autoimmune Diseases to Drive Demand for Efficient Gene Detection
The rising prevalence of autoimmune diseases is another crucial factor fueling the demand for gene detection. This diagnostic tool aids in identifying hereditary factors linked to autoimmune disease development. Currently, scientists have identified around eighty autoimmune diseases, affecting approximately 4% of the global population. Common autoimmune diseases include type 1 diabetes, rheumatoid arthritis, multiple sclerosis, scleroderma, Crohn’s disease, lupus, and psoriasis. As autoimmune diseases contribute to chronic illness, the need for efficient gene detection tests and services remains high.
Companies are responding to this demand by developing advanced gene detection methods, including sequencing and reverse transcription-polymerase chain reaction (RT-PCR), further bolstering the gene detection market’s growth potential.
Rising COVID-19 Cases Impact Gene Detection Market
The COVID-19 pandemic has intensified the production of genetic test kits, particularly for detecting the SARS-CoV-2 virus. Increasing COVID-19 cases have raised safety concerns in healthcare facilities, prompting additional testing efforts. Rapid gene detection tests like AvellinoCoV2 have gained prominence in diagnosing COVID-19 by isolating genetic markers, as approved by the CDC and FDA. Concerns over the ongoing pandemic continue to influence the demand for advanced diagnostics, thereby impacting the gene detection market.
North America Leads Growth in Gene Detection Market
North America is expected to remain at the forefront of gene detection market growth due to increasing demand for gene detection in analyzing ancestry-related issues. Moreover, the region grapples with a high prevalence of autoimmune diseases, spurring the adoption of advanced gene detection methods and kits. According to the National Institute of Environmental Health Sciences (NIH), autoimmune diseases affect approximately 24 million individuals in the United States, with the rate projected to rise. This has prompted the use of gene detection kits to mitigate autoimmune diseases and reduce associated healthcare costs.
The presence of key players engaged in research and innovation, coupled with FDA approvals for gene detection products, further propels the gene detection market in North America. For instance, the FDA approved FoundationOne Liquid CDx, a gene detection test developed by Foundation Medicine Inc., based on liquid biopsy next-generation sequencing (NGS).
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/gene-detection-market
Visit Our Blogs:
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Fairfield Market Research
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
This press release first seen on Brilad